- Trials with a EudraCT protocol (10)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
10 result(s) found for: Induced coma.
Displaying page 1 of 1.
EudraCT Number: 2009-017499-26 | Sponsor Protocol Number: Heres | Start Date*: 2010-03-16 | ||||||||||||||||||||||||||
Sponsor Name:Academical Medical Center, University of Amsterdam | ||||||||||||||||||||||||||||
Full Title: The use of Helium after Resuscitation: a safety and feasibility study | ||||||||||||||||||||||||||||
Medical condition: Persistent coma after cardiac arrest. | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: NL (Ongoing) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002170-36 | Sponsor Protocol Number: 2014-002170-36 | Start Date*: 2015-02-11 |
Sponsor Name:Karolinska University Hospital | ||
Full Title: Treatment of Cervical Spinal Cord Injury with Imatinib – a safety and feasibility study | ||
Medical condition: Cervical Spinal Cord Injury | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-003349-12 | Sponsor Protocol Number: NUIG-2020-003 | Start Date*: 2020-10-09 |
Sponsor Name:NUIG | ||
Full Title: Can Nebulised HepArin Reduce acuTE lung injury in Patients with SARS-CoV-2 Requiring Advanced Respiratory support in Ireland | ||
Medical condition: This trial will be carried out in invasively ventilated ICU patients with suspected or confirmed COVID-19 infection | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IE (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-003829-15 | Sponsor Protocol Number: AID-ICU | Start Date*: 2017-11-30 |
Sponsor Name:Zealand University Hospital | ||
Full Title: Agents Intervening against Delirium in the Intensive Care Unit (AID-ICU) | ||
Medical condition: Treatment of delirium in critically ill adult patients in intensive care unit. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) FI (Completed) ES (Ongoing) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2013-004708-20 | Sponsor Protocol Number: RIFSYS | Start Date*: 2014-03-27 | ||||||||||||||||
Sponsor Name:King's College London [...] | ||||||||||||||||||
Full Title: A placebo controlled single centre double blind randomised trial to investigate the efficacy of rifaximin versus placebo in improving systemic inflammation and neutrophil malfunction in patients wi... | ||||||||||||||||||
Medical condition: Cirrhosis and chronic hepatic encephalopathy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-015396-27 | Sponsor Protocol Number: NCTU:ISRCTN52164803 | Start Date*: 2010-01-28 |
Sponsor Name:Newcastle upon Tyne Hospitals NHS Foundation Trust | ||
Full Title: Prevention of Recurrent Severe Hypoglycaemia: a Definitive RCT Comparing Optimised MDI and CSII with or without Adjunctive Real-time Continuous Glucose Monitoring. | ||
Medical condition: Type 1 diabetes mellitus | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-000249-38 | Sponsor Protocol Number: R118439 | Start Date*: 2019-01-25 | |||||||||||
Sponsor Name:University of Manchester | |||||||||||||
Full Title: Phase II trial of interleukin-1 receptor antagonist in intracerebral haemorrhage: BLOcking the Cytokine IL-1 in ICH | |||||||||||||
Medical condition: intracerebral haemorrhage | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-004323-37 | Sponsor Protocol Number: PEARL-trial | Start Date*: 2019-06-06 | ||||||||||||||||||||||||||
Sponsor Name:Academic Medical Centre | ||||||||||||||||||||||||||||
Full Title: Prevention of hepatic Encephalopathy by Administration of Rifaximin and Lactulose in patients with liver cirrhosis undergoing placement of a transjugular intrahepatic portosystemic shunt: a multi-c... | ||||||||||||||||||||||||||||
Medical condition: post-TIPS Hepatic Encephalopathy (HE) | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: NL (Trial now transitioned) BE (Trial now transitioned) | ||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-014545-83 | Sponsor Protocol Number: C10953/3067/ES/MN | Start Date*: 2010-02-24 | ||||||||||||||||
Sponsor Name:Cephalon Inc. | ||||||||||||||||||
Full Title: A 12-week, randomized, double-blind, placebo-controlled, parallel-group. fixed-dosage study to evaluate the efficacy and safety of armodafinil (50, 150, and 250 mg/day) as treatment for patients wi... | ||||||||||||||||||
Medical condition: Patients with excessive Sleepiness associated with mild or moderate closed Traumatic Brain Injury (TBI) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Prematurely Ended) DE (Prematurely Ended) FR (Completed) CZ (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2009-014544-11 | Sponsor Protocol Number: C10953/3069/ES/MN | Start Date*: 2010-05-21 | ||||||||||||||||
Sponsor Name:Cephalon Inc | ||||||||||||||||||
Full Title: Estudio abierto de 12 meses para la evaluación de la seguridad, la tolerabilidad y la eficacia de armodafinil (150 mg/día y 250 mg/día) como tratamiento para pacientes con somnolencia excesiva asoc... | ||||||||||||||||||
Medical condition: Pacientes con somnolencia excesiva asociada a un trauma craneo-cerebral no penetrante leve o moderado. Excessive sleepiness accociated with mild or moderate closed traumatic brain injury | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Prematurely Ended) DE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
